🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to determine whether the recurrence rate of high-risk acute...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-01-01
Trial ID
NCT07101588
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This is a multi-center, single-arm, open-label, phase II trial for the fron...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2020-02-17
Trial ID
NCT04055844
Treatments Being Tested
ABNL-MARRO (A Basket study of Novel therapy for untreated MDS/MPN and Relap...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2021-11-24
Trial ID
NCT04061421
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ruxolitinib...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-02-12
Trial ID
NCT02257138
Treatments Being Tested
This phase II trial studies how well decitabine with ruxolitinib, fedratini...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-03-24
Trial ID
NCT04282187
Treatments Being Tested
The purpose of this study is to test the safety and tolerability of ruxolit...
Status
Completed
Location
Washington University of St. Louis
Start Date
2014-02
Trial ID
NCT02076191
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of Ruxoli...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2020-09-01
Trial ID
NCT04582604
Treatments Being Tested